As botulinum toxin treatments have become more popular, more people are undergoing repeated procedures. According to the 2025 Korean Consumer Survey on Botulinum Toxin conducted by the Expert Committee on the Safe Use of Botulinum Toxin, people aged 20 to 29 accounted for the largest share of first-time patients at 37%, while 57% of respondents said they received treatments at least twice a year on average. Treatment areas have also expanded from the face to the body. Choi Ho Sung, director of Rieul Dermatology Clinic, said, "As 'body toxin' treatments for areas such as the trapezius muscles and calves have become popular, cases involving injections of 200 to 300 units have also increased."
◇Frequent Treatments Raise Concerns About 'Neutralizing Antibodies'
One issue requiring caution as treatments become more frequent or doses increase is neutralizing antibodies. When neutralizing antibodies against the toxin form, the drug's efficacy may decline or the treatment may have no effect. Choi said, "Although it is easy to regard the treatment lightly because it is for cosmetic purposes, patients who do not see results experience considerable disappointment and stress," adding, "It is difficult to predict when the effect will return, and in some cases, patients may have to wait for several years."
The basic principle is to maintain an interval of about three months between treatments and not receive too large a dose at once. However, antibodies can still develop even when these guidelines are followed, making product selection important.
The same applies to patients receiving the treatment for the first time. If the toxin to which they are first exposed has low purity or contains a large amount of impurities, neutralizing antibodies may form even if they later switch to another product.
◇Three Factors to Consider When Choosing a Toxin
The product selection criteria presented by Choi Ho Sung include ▲the manufacturing process and purity, ▲long-term clinical data, and ▲whether it has received regulatory approval. The manufacturing process and purity are indicators of product quality. He said, "The manufacturing process is an area that practitioners cannot directly control," adding, "Even if medical professionals administer the treatment accurately, there are limits if the quality of the product itself is not sufficient."
The second factor is clinical data that can confirm whether the treatment's efficacy and duration of effect are consistent. Data examining efficacy and safety, particularly with repeated administration, are important.
The third factor is whether the product has been approved by regulatory agencies such as the U.S. Food and Drug Administration, or FDA. Choi Ho Sung said, "There are various toxins on the market, but the products approved by the FDA are limited," adding, "Both the approval status and clinical evidence should be reviewed."
Among products developed and used in Korea, Nabota has met these criteria. It is produced through a patented process and a vacuum-drying process, with a purity of at least 98% based on the 900kDa, kilodalton, complex. It has received approval from the FDA, the European Medicines Agency, or EMA, and Health Canada. In studies involving more than 1,500 people who received up to four repeated doses over one year or doses of up to 360 units, no cases of newly formed neutralizing antibodies were identified.
◇"The Effect Should Remain Consistent Even After 10 to 20 Treatments"
Consistency of results is also important with repeated treatments. A longer duration of effect is not necessarily better. The effect must appear accurately and consistently. Choi Ho Sung said, "Even if patients undergo repeated treatments 10 to 20 times, there should be no dissatisfaction with the duration of the effect," adding, "Particularly in small, thin muscles such as those around the eyes or between the eyebrows, side effects can occur if the drug spreads to unintended muscles, making accuracy and consistency of the effect important."
Patients who are likely to undergo repeated treatments should be especially careful when selecting a product. The same applies to those who begin treatment in their 20s. Botulinum toxin should not be viewed simply as a product for smoothing wrinkles, and patients should not automatically choose the least expensive product without considering safety and efficacy.
Choi said, "Considering that people are living to 100, it is worth thinking about whether long-term, repeated exposure to the toxin is desirable, given that some people may undergo treatments for more than 60 or 70 years." He added, "Botulinum toxin treatments can develop in a healthy manner only if both patients and medical professionals change their perceptions of the products and treatments and strengthen their ethical responsibilities."
[Check These Before Treatment]
①Treatment history: Confirm whether you have previously received treatment, and tell the medical professional the date and area of your most recent treatment, the product name, and the dose administered. Because the treatment interval and dose vary depending on an individual's condition and purpose, establish a specific treatment plan through consultation.
②Treatment interval and dose: The treatment interval and dose can affect not only efficacy but also side effects. Repeating treatments at short intervals to see results quickly or administering an excessive dose at once can be dangerous. Before treatment, learn about possible side effects, such as drooping eyelids, and precautions to take after the procedure.
③Medical professional's experience: During the consultation before treatment, confirm whether the medical professional has extensive experience with the procedure and a strong knowledge of anatomy. For medical institutions, it is also necessary to check whether they have a system in place to respond to side effects. Do not choose a medical institution based solely on price.
This article has been translated AI.
by Shin So Young
View All Articles
Copyright © Health Chosun. No unauthorized reproduction or redistribution.